Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.10.2020 | Case report

Micafungin/posaconazole/voriconazole

Lack of efficacy: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Bernardo V, et al. Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole. Pediatric Transplantation 24: No. 6, Sep 2020. Available from: URL: http://doi.org/10.1111/petr.13777 Bernardo V, et al. Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole. Pediatric Transplantation 24: No. 6, Sep 2020. Available from: URL: http://​doi.​org/​10.​1111/​petr.​13777
Metadaten
Titel
Micafungin/posaconazole/voriconazole
Lack of efficacy: 2 case reports
Publikationsdatum
01.10.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-84971-x

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Melphalan

Case report

Rituximab

Case report

Ganciclovir